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Abstract. 
 
Neuronal nicotinic 
 
a
 
7 subunits assemble into 
cell-surface complexes that neither function nor bind
 
a
 
-bungarotoxin when expressed in tsA201 cells. Func-
tional 
 
a
 
-bungarotoxin receptors are expressed if the 
membrane-spanning and cytoplasmic domains of the 
 
a
 
7 
subunit are replaced by the homologous regions of the 
serotonin-3 receptor subunit. Bgt-binding surface re-
ceptors assembled from chimeric 
 
a
 
7/serotonin-3 sub-
units contain subunits in two different conformations as 
shown by differences in redox state and other features 
of the subunits. In contrast, 
 
a
 
7 subunit complexes in the 
same cell line contain subunits in a single conformation. 
The appearance of a second 
 
a
 
7/serotonin-3 subunit 
conformation coincides with the formation of 
 
a
 
-bunga-
rotoxin–binding sites and intrasubunit disulﬁde bond-
ing, apparently within the 
 
a
 
7 domain of the 
 
a
 
7/seroto-
nin-3 chimera. In cell lines of neuronal origin that 
produce functional 
 
a
 
7 receptors, 
 
a
 
7 subunits undergo a 
conformational change similar to 
 
a
 
7/serotonin-3 sub-
units. 
 
a
 
7 subunits, thus, can fold and assemble by two 
different pathways. Subunits in a single conformation 
assemble into nonfunctional receptors, or subunits ex-
pressed in specialized cells undergo additional process-
ing to produce functional, 
 
a
 
-bungarotoxin–binding re-
ceptors with two 
 
a
 
7 conformations. Our results suggest 
that 
 
a
 
7 subunit diversity can be achieved postransla-
tionally and is required for functional homomeric re-
ceptors.
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I
 
ONOTROPIC
 
 neurotransmitter receptors rapidly trans-
duce the chemical signal of the neurotransmitter into
an electrical signal at the synapse. Recent studies have
established the primary structure of the receptor subunits
and provided detailed information about the structure,
electrophysiology, and pharmacology of these membrane
proteins. In contrast to the ubiquitous studies of receptor
structure-function, there have been surprisingly few inves-
tigations into the processing, folding, and assembly of
newly synthesized receptor subunits. These events appear
to be rate-limiting during neurotransmitter receptor bio-
genesis (Green and Millar, 1995), and are likely to play an
important role in controlling synaptic efficacy by regulat-
ing the number of functional receptors at synapses.
In this study, we investigated the processing of a neu-
ronal nicotinic acetylcholine receptor (AChR)
 
1
 
 subunit.
AChRs are a class of neurotransmitter receptors com-
prised of five subunits that surround a central aqueous
pore. All AChR subunits share a common membrane to-
pology and significant sequence homology (Unwin, 1993;
Karlin and Akabas, 1995; Lindstrom, 1995). These same
structural features are common to a family of neurotrans-
mitter-gated ion channels that includes cationic channels,
acetylcholine (ACh) and serotonin-3 or 5-hydroxytryp-
tamine-3 (5HT
 
3
 
) receptors, and anionic channels, 
 
g
 
-ami-
nobutyric acid-A (GABA
 
A
 
), and glycine receptors. The
best characterized members of this family are the muscle-
type AChRs, which consist of a homogenous population of
receptors at the neuromuscular junction. In the nervous
system, there is considerable diversity in the properties of
AChRs, which is due in part to the array of subunit types
expressed by neurons. There are eight different ligand-
binding subunits (
 
a
 
2–
 
a
 
9) and three structural subunits
(
 
b
 
2–
 
b
 
4) that are found primarily in the nervous system
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1. 
 
Abbreviations used in this paper:
 
 5HT, 5-hydroxytryptamine (seroto-
nin); ACh, acetylcholine; AChR, acetylcholine receptor; Bgt, 
 
a
 
-bungaro-
toxin; BgtR, 
 
a
 
-bungarotoxin receptor; HA, hemagglutinin; NEM, 
 
N
 
-eth-
ylmaleimide; TMR-Bgt, 
 
a
 
-bungarotoxin tetramethylrhodamine. 
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(Sargent, 1993; McGehee and Role, 1995; Role and Berg,
1996). These subunit isoforms have distinct, although
overlapping, patterns of expression and assemble into re-
ceptor subtypes with different pharmacological and func-
tional properties.
In the nervous system, there are large numbers of high-
affinity binding sites for the muscle AChR selective antag-
onist, 
 
a
 
-bungarotoxin (Bgt). Early observations that these
sites did not correlate directly with high-affinity nicotine
binding, combined with a lack of evidence for Bgt-sensi-
tive nicotinic responses in neurons, led to confusion about
the function of these binding sites (for review see Clarke,
1992). This apparent contradiction was resolved, in part,
by the cloning of 
 
a
 
7 subunits and their expression in 
 
Xeno-
pus
 
 oocytes which produced nicotine-gated currents that
are potently inhibited by Bgt (Couturier et al., 1990;
Schoepfer et al., 1990; Seguela et al., 1993). Recent stud-
ies have shown that functional Bgt-binding receptors
(BgtRs) are expressed in many parts of the nervous system
(Zorumski et al., 1992; Alkondon and Albuquerque, 1993;
Zhang et al., 1994), and may be homomeric receptors
composed of five 
 
a
 
7 subunits (Chen and Patrick, 1997;
Rangwala et al., 1997). The BgtR ion channel is highly
permeable to Ca
 
2
 
1
 
 (Seguela et al., 1993; Castro and Albu-
querque, 1995), enabling subsequent activation of Ca
 
2
 
1
 
-
dependent events in neurons including the presynaptic en-
hancement of neurotransmitter release (Vijayaraghavan
et al., 1992; McGehee et al., 1995; Alkondon et al., 1996;
Gray et al., 1996). Other studies have shown that activa-
tion of BgtRs can result in neurite retraction (Chan and
Quik, 1993; Pugh and Berg, 1994) and that their expres-
sion is upregulated during the formation of thalamocor-
tical projections (Broide et al., 1996), consistent with a
developmental role for BgtRs in establishing cortical cir-
cuitry. In addition, BgtRs have been linked to a form of schizo-
phrenia (Freedman et al., 1994, 1997; Breese et al., 1997).
Although 
 
a
 
7 subunits form functional BgtRs in 
 
Xeno-
pus
 
 oocytes (Couturier et al., 1990; Schoepfer et al., 1990;
Seguela et al., 1993), most mammalian cells do not express
Bgt-binding sites when transfected with 
 
a
 
7 subunits (Coo-
per and Millar, 1997; Rangwala et al., 1997). It has been as-
sumed that the explanation for this difference was a failure
of subunits to be processed and assembled properly. Here,
we show that 
 
a
 
7 subunits do assemble and are inserted
into the plasma membrane, but that these receptors do not
function or bind Bgt. A comparison of these 
 
a
 
7 receptors
with Bgt-binding receptors revealed differences in pro-
cessing. In cells expressing Bgt-binding 
 
a
 
7 receptors,
subunits were folded into two different disulfide-bonded
conformations and surface receptors contained both con-
formations. In contrast, 
 
a
 
7 subunits were only folded into
a single conformation in cells expressing nonfunctional re-
ceptors. Our findings suggest that two different 
 
a
 
7 subunit
conformations in a receptor are required for receptor
function.
 
Materials and Methods
 
Subunit Constructs
 
Chick 
 
a
 
7 and chick 
 
a
 
7/5HT
 
3
 
 subunit cDNAs were gifts from Dr. J.L.
Eisele (Pasteur Institute, Paris, France). These cDNAs were subcloned
 
into a pMT3 expression vector (Swick et al., 1992). A cDNA construct was
generated in which the chick 
 
a
 
7 subunit was truncated just before the first
transmembrane domain at amino acid threonine 208 (West et al., 1997;
Wells et al., 1998). All subunits were tagged at the COOH terminus with
the hemagglutinin (HA) epitope, a stretch of nine amino acids (YPYD-
VPDYA; Wilson et al., 1984). The nine HA epitope codons (TACCCAT-
ACGACGTCCCAGACTACGCT) and a stop codon were inserted after
the last codon of the 3
 
9
 
 translated region of the three subunit cDNAs us-
ing the extension overlap method (Ho et al., 1989).
 
Cell Lines and Transfection
 
The human kidney epithelial cell line, tsA201 (gift from Dr. J. Kyle, Uni-
versity of Chicago, Chicago, IL), were maintained in DMEM supple-
mented with 10% calf serum (Hyclone). Cells were transiently transfected
with the subunit cDNA constructs using a calcium phosphate protocol
(Claudio, 1992). The PC12 cell isolate, N21, was a gift from Dr. Richard
W. Burry (Ohio State University, Columbus, OH) and was cultured in
DMEM supplemented with 10% fetal bovine serum and 5% heat inacti-
vated horse serum. SH-SY5Y human neuroblastoma cells, stably trans-
fected with the rat 
 
a
 
7 subunit cDNA (Puchacz et al., 1994), were a gener-
ous gift from Dr. R. Lukas (Barrow Neurological Institute, Phoenix, AZ).
Cells were maintained in the same medium as PC12 cells, with the addi-
tion of 400 
 
m
 
g/ml of hygromycin B.
 
Cell-surface 
 
125
 
I-Protein A and Bgt Binding
 
2 d after transfection, tsA201 cells from 6-cm cultures were removed from
the plates and washed with PBS. Under our culture conditions in which
the cells were not grown on any substrate, the transfected tsA201 cells
were poorly adherent. This property allowed the cells to be gently re-
moved from the plates and transferred into Eppendorf tubes. To estimate
levels of 
 
a
 
7 and 
 
a
 
7/5HT
 
3
 
 subunit expression, the transfected cells were in-
cubated with the anti-HA antibody, mAb 12CA5, in PBS containing 0.1%
BSA overnight at 4
 
8
 
C. mAb 12CA5 was harvested from hybridoma super-
natant and concentrated on a protein G–Sepharose (Pharmacia) column.
Cells were washed with cold PBS and centrifuged (5,000 
 
g
 
, 15 s) 3 times to
remove unbound antibodies, and then incubated with 0.5 
 
m
 
Ci per plate of
 
125
 
I-protein A (Amersham) in cold PBS-0.1% BSA solution for 3 h at 4
 
8
 
C.
Unbound radioactivity was removed by three washes in cold PBS and the
samples were counted in a Wallac 1470 gamma counter. To bind cell-sur-
face subunit receptors with Bgt, PC12 cells or cells transfected with 
 
a
 
7/
5HT
 
3
 
 were incubated with 12.5 nM cold Bgt (Biotoxins Inc.) for 2 h, and
washed with cold PBS and centrifuged (5,000 
 
g
 
, 15 s) 3 times to remove
unbound Bgt.
 
Metabolic Labeling, Immunoprecipitation, and 
Immunoblot Analysis
 
15 h after transfection, 6 cm cultures were starved in methionine-
free DMEM for 10–15 min and labeled in methionine-free DMEM con-
taining 100 
 
m
 
Ci/ml of an [
 
35
 
S]methionine [
 
35
 
S]cysteine mixture (NEN
EXPE
 
35
 
S
 
35
 
S) for the specified times. To follow the subsequent changes in
the labeled subunits, the cells were chased by incubation for the indicated
times in medium at 37
 
8
 
C. Cells that were chased were washed twice with
DMEM supplemented with 5 mM cold methionine and incubated at 37
 
8
 
C
in complete medium for the duration of the chase. Cells were then trans-
ferred from the plates into Eppendorf tubes, washed twice with PBS, and
solubilized in lysis buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris, pH
7.4, 0.02% NaN
 
3
 
) containing 2 mM phenylmethylsulfonyl fluoride, 10 
 
m
 
g/ml
each of chymostatin, leupeptin, pepstatin and tosyl-lysine chloromethyl
ketone, and 1% Triton X-100. Lysates were clarified by centrifugation at
10,000 
 
g
 
 for 30 min at 4
 
8
 
C, and the supernatants precleared by incubation
with Sepharose 4B (Pharmacia) overnight at 4
 
8
 
C. The resin was removed
by centrifugation and the supernatant was rotated overnight at 4
 
8
 
C with
either saturating amounts of the anti-HA antibody, mAb 12CA5, or Bgt-
Sepharose. Bgt-Sepharose was prepared by coupling Bgt to CNBr-acti-
vated Sepharose 4B (Pharmacia) according to the manufacturer’s direc-
tions. The receptor-antibody complex was precipitated with protein
G–Sepharose. The resin was washed twice in lysis buffer similar to the one
used above, but with 500 mM NaCl instead of 150 mM and addition of
0.1% SDS, and twice with regular lysis buffer. Precipitates were eluted
from the beads with gel loading buffer and separated on 4–8% gradient
SDS-PAGE with the exception of the truncated 
 
a
 
7 construct where 10%
SDS-PAGE was used (see Fig. 3 D). Gels were stained, fixed, treated with 
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Amplify (Amersham) for 30 min, dried, and exposed to Kodak XRP film
at 
 
2
 
70
 
8
 
C with intensifying screens.
For immunoblots, confluent 10 cm cultures of PC12 and the SH-SY5Y
cells were treated, solubilized, and subunits precipitated with Bgt-
Sepharose as described above. PC12 cell-surface receptors bound with Bgt
were immunoprecipitated with anti-Bgt antibodies coupled to protein
A–Sepharose. Precipitates were eluted from the beads with gel loading
buffer and separated on 4–8% gradient SDS-PAGE. Proteins separated
by SDS-PAGE were electrophoretically transferred to nitrocellulose
membrane (Towbin et al., 1979) in a Hoefer transfer unit. After transfer,
the nitrocellulose was treated with 3% BSA in wash buffer (10 mM Tris,
pH 7.4, 0.05% Tween 20, 150 mM NaCl), washed briefly in the wash
buffer, and then incubated with the primary antibody in wash buffer con-
taining 0.3% BSA for 1 h at room temperature. Membranes were first
probed with C-20 (Santa Cruz Biotechnology), an anti–
 
a
 
7 polyclonal anti-
body (1:1,000 dilution). The membrane was washed and incubated by rab-
bit anti–goat-HRP antibody (at 1:100,000 dilution), and then treated with
an enhanced chemiluminescent reagent (ECL, Amersham) according to
the manufacturer’s protocol and exposed to Kodak XLS film.
 
Immunofluorescence Staining
 
Live, intact cells were stained with an 
 
a
 
-bungarotoxin tetramethyl-
rhodamine conjugate (TMR-Bgt) used at 300 nM (Molecular Probes) and
a mouse monoclonal anti-HA antibody used at 1:1,000 (BAbCO). The
secondary antibody (used at 1:500) was an affinity-purified fluorescein
isothiocyanate conjugated goat anti–mouse immunoglobin (Molecular
Probes). Nuclei were stained with DAPI (Molecular Probes). Transiently
transfected cells were immobilized on Alcian blue (Eastman Kodak)
coated slides, fixed with 2% paraformaldehyde (Sigma), and preblocked
with TBS supplemented with 2 mg/ml BSA (Sigma), TBS/BSA. Primary
and secondary Abs, as well as TMR-Bgt, were diluted in TBS/BSA and al-
lowed to react with cells for 1 h at room temperature. After each incuba-
tion, cells were rinsed 3 times, 5–10 min each time, with TBS/BSA. Cells
were mounted in Vectashield (Vector Laboratories), viewed, and photo-
graphed with a Zeiss Axioplan microscope using a 100
 
3
 
 1.4 NA Plan Apo
objective.
 
Electrophysiology
 
Cells expressing 
 
a
 
7 or 
 
a
 
7/5HT
 
3
 
 on their surface were visualized by means
of an inverted microscope equipped with epifluorescence illumination and
Hoffman optics (Zeiss Axiovert 135). Membrane currents were measured
with the whole-cell configuration of the patch clamp technique (Hamill
et al., 1981) using an Axopatch 200B amplifier (Axon Instruments). The
criterion for adequate electrical access was 10 M
 
V
 
 or less, as determined
by the compensation circuitry of the patch clamp. The pipette solution in-
cluded (mM) 140 K-gluconate, 10 KCl, 1 EGTA, 5 K-ATP, 10 Hepes, 10
glucose, pH, 7.4. The external solution included (mM) 145 NaCl, 2.5 KCl,
1 MgCl
 
2
 
, 1 CaCl
 
2
 
, 10 glucose, 10 Hepes, pH, 7.4. Nicotine was applied by
means of a perfusion system with a solution exchange time from 20–100
ms and experiments were carried out at 22–24
 
8
 
C. Membrane currents
were digitized and analyzed using a microcomputer (Dell Pentium 200
MHz) equipped with a Digidata 1200 A/D interface and PClamp 6.0 soft-
ware (Axon Instruments).
 
Results
 
Cell-surface 
 
a
 
7 Subunits That Do Not Bind Bgt
 
Heterologous expression of 
 
a
 
7 subunits in many different
cell lines results in little to no expression of Bgt-binding
sites (Cooper and Millar, 1997; Rangwala et al., 1997). In
contrast, expression of a chimeric subunit, composed of
the extracellular NH
 
2
 
-terminal half of the 
 
a
 
7 subunit and
the COOH-terminal half of the 5HT
 
3
 
 subunit, produces
high levels of Bgt-binding sites (Corringer et al., 1995;
Rangwala et al., 1997). To address whether 
 
a
 
7 subunits
lacking Bgt-binding sites arrive at the surface of cells, we
generated a fusion protein of the 
 
a
 
7 subunit with a HA
epitope tag on the COOH terminus (
 
a
 
7-HA). The same
 
HA epitope tag was also fused to the COOH terminus of
the 
 
a
 
7/5HT
 
3
 
 chimeric subunit. As illustrated in Fig. 1 A,
the HA epitope was expected to have an extracellular lo-
cation, given the predicted membrane topology. Intact
cells expressing 
 
a
 
7/5HT
 
3
 
-HA subunits were intensely stained
by the anti-HA mAb (Fig. 1 B), and we conclude that the
HA epitope and the COOH terminus of the 
 
a
 
7/5HT
 
3
 
-HA
subunits are located in the extracellular domain of the re-
ceptor. Transient transfection of 
 
a
 
7/5HT
 
3
 
-HA subunits in
tsA201 cells results in expression in 
 
z
 
50% of the cells as
determined by comparing DAPI nuclei staining (Fig. 1 B,
left panels) with the anti-HA mAb staining. Consistent
with Bgt binding to these receptors, all cells stained by the
anti-HA mAb were also highly stained by TMR-Bgt (Fig.
1 B, middle panels).
In light of earlier findings that expression of 
 
a
 
7 subunits
does not produce Bgt-binding sites, it was surprising that
large numbers of the cells transfected with the 
 
a
 
7-HA sub-
unit stained positive with the anti-HA mAb (Fig. 1 B). As
expected, no cells stained positive with TMR-Bgt. Thus,
 
a
 
7-HA subunits on the surface of these cells lack Bgt-
binding sites. The relative amounts of cell-surface 
 
a
 
7-HA
and 
 
a
 
7/5HT
 
3
 
-HA subunits were determined using the
anti-HA mAb and 125I-protein A. Fig. 1 C illustrates that
a7/5HT3-HA subunit expression was sixfold higher than
a7-HA subunit expression. The reason for the difference
in the levels of surface expression is unclear, but it is not
caused by differences in rates of a7-HA and a7/5HT3-HA
subunit synthesis (see Figs. 3 and 4).
Surface a7 Subunit Complexes Are Nonfunctional
Since significant numbers of a7 subunits are transported
to the surface of transfected cells, we examined whether
these subunits form functional receptors. We tested the
nicotine sensitivity of tsA201 cells transfected with the a7/
5HT3-HA construct and stained with the anti-HA anti-
body. In whole-cell voltage clamp recordings, 15 of 15 cells
responded to nicotine with robust inward currents that de-
sensitized in the continued presence of the agonist, as ex-
pected for an AChR-mediated response (Fig. 2 A). In the
same cultures, cells that did not stain positive with the
anti-HA antibody did not respond to nicotine application
(n 5 12; not shown). In contrast to the cells expressing a7/
5HT3-HA, the application of nicotine to a7-HA–trans-
fected cells that stained with anti-HA antibody, did not
elicit any response (n 5 11; Fig. 2 B). These findings indi-
cate that the a7-HA subunit complexes expressed on the
surface of these cells do not form functional receptors.
Differences in a7 and a7/5HT3 Subunit Redox State
To identify the basis for the differences between a7-HA
and a7/5HT3-HA subunits, we performed a series of ex-
periments that compared the processing of the two sub-
units. For the muscle-type AChR, formation of the Bgt-
binding site requires disulfide bonding of two cysteine
residues in the extracellular, NH2-terminal domain of the
a1 subunit (Mishina et al., 1985; Sumikawa and Gehle,
1992; Green and Wanamaker, 1997). Because a homolo-
gous set of cysteine residues is found on the extracellular,
NH2-terminal domain of a7 and a7/5HT3 subunits, we
tested whether the subunits differ in their redox state. IfThe Journal of Cell Biology, Volume 146, 1999 206
the alkylating agent, N-ethylmaleimide (NEM), is not
present during solubilization of the labeled subunits, the
migration of a7 subunits on nonreducing gels was distinct
from a7/5HT3 subunits (Fig. 3 A, lanes 1 and 2). Under
these conditions, none of the metabolically labeled a7 sub-
units migrated at the expected position of z60 kD (Coutu-
rier et al., 1990; Schoepfer et al., 1990). Instead, a7 sub-
units migrated as aggregates, i.e., in a broad mass at much
higher molecular weights. Metabolically labeled a7/5HT3
subunits, in contrast, migrated at the expected molecular
weight of an z60-kD monomer, although some of the la-
beled a7/5HT3 subunits also migrate as aggregates. The
differences in the migration of labeled a7/5HT3 and a7
subunits under these conditions indicate that the two sub-
units differ in their redox state.
Subunit aggregation is caused by disulfide bonding of
the subunits since no a7 or a7/5HT3 subunit aggregates
are observed on reducing gels (Fig. 3 A, lanes 3 and 4), and
Figure 1. Cell-surface a7 sub-
units that do not bind Bgt. (A)
HA epitope-tagged a7-HA and
a7/5HT3-HA subunits. Dia-
grammed are the a7 and chi-
meric  a7/5HT3 subunits and the
location of the HA epitope. M1–
M4 represent putative trans-
membrane domains. Based on
the consensus membrane topol-
ogy of the subunits shown on the
bottom of the figure, the HA
epitope tag on the COOH ter-
minus of the subunits should be
located within the extracellular
domain of the receptors. Also
diagrammed is the a7 subunit
construct (Ta7-HA), which is
truncated just before the first
transmembrane domain (M1)
and also contains the HA
epitope tag at the COOH termi-
nus. (B) Immunostaining of a7/
5HT3-HA and a7-HA subunits on the cell surface. TsA201 cells, transfected with either a7/5HT3-HA or a7-HA cDNA constructs, were
immobilized on slides and immunostained using an anti-HA mAb. Photographs were taken sequentially in the same field after staining
with a nuclear stain, DAPI (blue), TMR-Bgt (red), and anti-HA mAb complexed with fluorescein-conjugated secondary Ab (green).
DAPI staining is included to stain untransfected as well as transfected cells. Bar, 10 mm. Note the difference in scale. The cells express-
ing a7/5HT3-HA were photographed with a 1003 objective whereas those expressing a7-HA were photographed with a 633 objective.
(C) 125I-protein A binding to surface a7/5HT3-HA and a7-HA subunits. TsA201 cells were transiently transfected with either a7-HA,
a7/5HT3-HA, or a7/5HT3 cDNA in 6-cm plates. To compare subunit surface expression levels 48 h after transfection, cells were incu-
bated with saturating concentrations of anti-HA mAb and 125I-protein A, and specific binding was determined. Each bar represents the
mean of three determinations 6 SD.Rakhilin et al. Two Disulfide-bonded Conformations of a7 Subunits 207
the subunits run predominantly as monomers at z60 kD.
The very broad distribution of the aggregates on nonre-
ducing gels further suggests that the subunits are disulfide
bonded randomly to other proteins, as well as to each
other. Surprisingly, aggregation of a7 subunits was pre-
vented if NEM was added during solubilization of the sub-
units (Fig. 3 C) or even if intact cells were briefly exposed
to NEM concentrations as low as 100 mM before solubili-
zation (Fig. 3 B). For alkylation to prevent disulfide-linked
subunit aggregation, a7 subunits must contain free sulfhy-
dryl groups that can be alkylated before subunit aggrega-
tion. Because subunit aggregates are prevented by subunit
alkylation, we conclude that aggregates are absent in vivo
and must form during solubilization. Furthermore, the a7
subunit free sulfhydryl groups that can be alkylated in in-
tact cells are somehow prevented from forming disulfide
bonds, and this obstacle is removed during solubilization.
Aggregation of the a7/5HT3 subunits, which occurred to a
lesser extent than the aggregation of a7 subunits (Fig. 3
A), was also prevented by alkylation of the subunits with
NEM (Figs. 3 D and 4 B).
In addition to aggregates and subunit monomers on the
gels, a7 and a7/5HT3 subunits ran as a ladder of higher
molecular weight bands where each rung was a multiple of
the monomer (Fig. 3, A, C, and D). Bands corresponding
to subunit dimers, trimers, tetramers, and pentamers were
observed, but there were no complexes larger than pen-
tamers (see Figs. 4–6). These data are consistent with a7
subunits complexing into pentamers, similar to a7/5HT3
subunit receptors (Rangwala et al., 1997) and other char-
acterized AChRs (Karlin and Akabas, 1995). For a7 sub-
units, a large number of the multimers was present even
on reducing gels or alkylated with NEM, though alkylation
did disperse some of the larger multimers (Fig. 3 C). Since
most of the a7 multimers remained tightly associated even
in the presence of SDS, they must be held together by
SDS-resistant associations in addition to any disulfide
bonds.  a7/5HT3 subunit multimers were also observed and
most remained intact on reducing gels or after NEM al-
kylation (Figs. 3 A and 4 B). These SDS-resistant associa-
tions between subunits are similar to those observed for
other oligomeric proteins such as K1 channel subunits
(Cortes and Perozo, 1997). a7/5HT3 subunit multimers,
precipitated with Bgt-affinity resin, were dispersed after
NEM alkylation and reduction (Fig. 3 D). Thus, there was
a loss of the SDS-resistant subunit associations after Bgt-
binding sites appeared on a7/5HT3 subunits.
A similar set of experiments was performed using an a7
subunit construct truncated just before the first transmem-
brane domain (Ta7-HA; Fig. 1 A). These truncated a7
subunits assemble into pentameric complexes, and a small
percentage of the subunits binds both Bgt and agonists
(Wells et al., 1998). The truncated subunits were metaboli-
cally labeled after transient expression in tsA201 cells and
immunoprecipitated with the anti-HA mAb. In several re-
spects, the redox state of the truncated subunits was simi-
lar to that of the full-length a7 subunits under similar con-
ditions. On nonreducing gels in the absence of NEM
alkylation, most of the truncated subunits migrated as ag-
gregates (Fig. 3 E, lane 1). With or without NEM in the
solubilizing buffer, subunit multimers corresponding to
truncated subunit monomers through pentamers were ob-
served (Fig. 3 E, lanes 1 and 2; Fig. 3 F). Since both the
truncated subunit aggregates and multimers were absent
on reducing gels (Fig. 3 E, lane 3), the aggregates and mul-
timers resulted from disulfide bonds between the subunits.
The ability of the truncated a7 subunits to form disulfide-
bonded aggregates and multimers similar to the full-length
a7 subunits indicates that the disulfide bonding occurs be-
tween the extracellular NH2-terminal domains of the sub-
units. It should also be noted that there were differences
between the truncated and full-length a7 subunits. On
Figure 2. a7 subunit complexes are nonfunctional. (A) Whole-
cell response to nicotine for cells expressing a7/5HT3-HA sub-
units. a7-5HT3-HA transfected cells were identified by positive
staining with anti-HA mAb, and whole cell patch clamp record-
ings showed functional nicotine-gated currents at a potential of
270 mV (100 mM nicotine; similar responses were seen in 15 of
15 cells). No responses were seen in cells that were not positively
stained with the anti-HA mAb (n 5 12). (B) Whole-cell response
to nicotine for cells expressing a7-HA subunits. Transfection
with  a7-HA results in positive staining of live cells, but no inward
currents were seen at holding potentials of 270 mV. In total, 11
cells were exposed to a 10-fold higher nicotine concentration
(1 mM). Except for their response to nicotine, cells expressing
a7-HA subunits appeared to be identical to cells expressing
a7/5HT3-HA subunits.The Journal of Cell Biology, Volume 146, 1999 208
nonreducing gels in the absence of NEM alkylation, some
truncated subunits migrated as monomers. In addition, the
truncated subunit multimers totally disappeared on reduc-
ing gels (Fig. 3 E, lane 3), and thus, did not display the
SDS-resistant associations of the full-length a7 subunits.
Disulfide Bond Formation and the Change in a7/5HT3 
Subunit Redox State
Although subunit aggregates are artifacts of solubilization,
their appearance can be used as an assay of the a7 and a7/
5HT3 subunit redox state. Cells expressing either subunit
were briefly metabolically labeled and the redox state of
the subunits was assayed at different times after labeling
(Fig. 4, A and B). Immediately following subunit synthe-
sis, a7 subunits were in a state that resulted in subunit ag-
gregates during solubilization and remained in that state
after synthesis (Fig. 4 A). Virtually all of the a7/5HT3 sub-
units were also in aggregates on the gels following their
synthesis (Fig. 4 B, second gel, lane 2). However, unlike
Figure 3. Differences in the
folding of a7-HA and a7/5HT3-
HA subunits. (A) A difference
in a7 and a7/5HT3 subunit re-
dox state. 6-cm cultures of
tsA201 cells, transfected with
a7-HA or a7/5HT3-HA cDNAs,
were metabolically labeled for
1 h and chased for 1 h. The cells
were solubilized in the absence
of NEM and labeled subunits
immunoprecipitated with anti-
HA mAb. Samples, each from
one 6-cm culture, were loaded
on the gel with or without treat-
ment with 10 mM DTT. a7-HA
samples were loaded into lanes 1
and 3 and a7/5HT3-HA samples
were loaded into lanes 2 and 4.
Arrows on the left of the figure
are the indicated molecular
weight markers run on a sepa-
rate lane. Arrows on the right of
the figure indicate positions of
monomer, dimer, trimer, tet-
ramer, and pentamer subunit
complexes. (B) a7 subunit alkyl-
ation prevents its aggregation.
TsA201 cells were transfected
with a7-HA cDNA, metaboli-
cally labeled, and precipitated as
in A, except that NEM (0–100
mM) was included in the culture
medium for the final 10 min of
the chase. A sample from sham-
transfected cells (no DNA) was
run in lane 1. Arrows on the left
and right of the figure are the
same as in A. (C) SDS resis-
tance of subunit multimers.
TsA201 cells were transfected
with a7-HA cDNA, metaboli-
cally labeled, and precipitated as in A. As indicated, NEM (2 mM) was added to the solubilization buffer and to the loading buffer after
addition of DTT (1 mM). After alkylation by NEM (lane 3) and reduction by DTT before gel loading (lane 4), some subunits remained
in complexes as well as migrating as monomers. Arrows on the left of the figure are the indicated molecular weight markers run on a
separate lane. Arrows on the right of the figure indicate positions corresponding to monomer, dimer, trimer, tetramer, and pentamer
subunit complexes. (D) Bgt-binding subunit multimers. TsA201 cells transfected with a7/5HT3-HA cDNA were metabolically labeled
as in A, chased for 2 h, and subunits precipitated with Bgt-Sepharose. Subunit multimers were greatly decreased by NEM alkylation (2
mM; lane 2) and addition of DTT before gel loading (1 mM; lane 3). A sample from sham-transfected cells (no DNA) was run in lane 1.
Molecular weight markers are on the left of the gel. (E and F) The truncated a7 subunit. TsA201 cells were transfected with the trun-
cated a7 subunit cDNA (Ta7-HA; Fig. 1 A), metabolically labeled, and immunoprecipitated as in A. Labeled subunits were analyzed
on 10% (E) or 4–8% gradient (F) gels. As indicated, NEM (2 mM) was added to the solubilization buffer and to the loading buffer after
addition of DTT (1 mM). Truncated a7 subunits migrated as aggregates and multimers similar to full-length a7 subunits (A–C). Arrows
on the left of the figures are the indicated molecular weight markers run on a separate lane. Arrows on the right of the figures indicate
positions corresponding to monomer, dimer, trimer, and tetramer (E and F) plus pentamer (F) subunit complexes.Rakhilin et al. Two Disulfide-bonded Conformations of a7 Subunits 209
the a7 subunits, a small fraction of the a7/5HT3 subunits
appeared as monomers on the gel and thus were in the dif-
ferent redox state. The number of a7/5HT3 subunit mono-
mers increased with time whereas the number of subunit
aggregates decreased until most of the a7/5HT3 subunits
migrated as monomers. Based on these results, we con-
clude that a7 and a7/5HT3 subunits are in a similar redox
state immediately following subunit synthesis. The differ-
ences observed between these subunits arise over time and
are caused by processing events that convert a7/5HT3 sub-
units from the redox state where subunits are aggregated
to the state where the subunits migrate as monomers on
the gels.
To test whether disulfide bonds form on a7/5HT3 sub-
units during the change in subunit redox state, the reduc-
ing agent, DTT, was applied to the cells after metaboli-
cally labeling the subunits (Fig. 4 C). When added to the
medium of cultures, DTT permeates cells and prevents the
formation of protein disulfide bonds in the ER as well as
reduces existing disulfide bonds without altering most
Figure 4. Disulfide bonding is required to effect
a change in a7/5HT3 subunit redox state. (A and
B) Time-dependent change in a7/5HT3-HA sub-
unit redox state. TsA201 cells transfected with
a7-HA (A) or a7/5HT3-HA (B) cDNAs were
metabolically labeled for 10 min and chased for
the times specified in the figure. The cells were
solubilized in the absence of NEM, labeled sub-
units immunoprecipitated with anti-HA mAb,
and samples loaded on the gels without (nonre-
ducing) or with (reducing) 10 mM DTT. A sam-
ple from sham-transfected cells (no DNA) was
run in lane 1 of each of the four gels. Arrows on
the right of the figure indicate positions of puta-
tive monomer, dimer, trimer, tetramer, and pen-
tamer a7/5HT3-HA subunit complexes. (C) Ad-
dition of 5 mM DTT to the cell medium blocks
the redox state change. TsA201 cells transfected
with a7/5HT3-HA cDNA were metabolically la-
beled for 10 min and chased for the times speci-
fied in the figure in the absence (left) or presence
(right) of 5 mM DTT in the medium. Cells were
solubilized in the absence of NEM and labeled
subunits precipitated with anti-HA mAb. All
samples were loaded on the gels without DTT,
and a sample from sham-transfected cells (no
DNA) was run in lane 1 (left and right). Arrows
on the right of the figure indicate positions of pu-
tative monomer, dimer, trimer, tetramer, and
pentamer  a7/5HT3-HA subunit complexes.The Journal of Cell Biology, Volume 146, 1999 210
other cellular functions (Braakman et al., 1992). After the
addition of 5 mM DTT, the a7/5HT3 subunits remained as
aggregates on the gels and all subsequent conversion to
monomers was blocked (Fig. 4 C). Note that the small
number of monomers observed in Fig. 4 C exist during the
pulse when no DTT was present and do not increase after
the addition of DTT. Therefore, addition of 5 mM DTT to
the cell medium after the subunits were labeled prevented
the change in a7/5HT3 subunit redox state. The effect of
DTT was reversible. If the DTT was removed from the
medium, a7/5HT3 subunit aggregates again converted into
the monomeric a7/5HT3 subunit conformation with time
(data not shown). Based on these data, we conclude that
disulfide bonds form on a7/5HT3 subunits during the
change in subunit redox state. The a7/5HT3 subunits,
which result from the redox state change, migrate as sub-
unit monomers on nonreducing gels with the exception of
the subunit multimers that form during solubilization in
the absence of subunit alkylation (see Fig. 3 D). The disul-
fide bonds that form during the redox state change, thus,
are intrasubunit bonds.
Bgt-binding Site Formation Coincides with the Change 
in a7/5HT3 Subunit Redox State
Since Bgt-binding sites form on a7/5HT3 subunits and not
on a7 subunits (Fig 1 B; Cooper and Millar, 1997; Rang-
wala et al., 1997), we tested whether Bgt-binding site for-
mation correlates with the change in a7/5HT3 subunit re-
dox state. To monitor Bgt-binding site formation, equal
aliquots of labeled a7/5HT3 subunits were precipitated us-
ing Bgt-Sepharose or with the anti-HA mAb at different
times after subunits were labeled (Fig. 5 A). A strong cor-
relation exists between the appearance of Bgt-Sepharose
Figure 5. Bgt-binding site for-
mation and the change in redox
state. (A) Formation of Bgt-
binding site correlates with the
change in redox state. TsA201
cells transfected with a7/5HT3-
HA cDNA were metabolically
labeled for 10 min and chased
for the times specified in the fig-
ure. The cells were solubilized in
the absence of NEM and labeled
subunits precipitated with anti-
HA mAb (lanes 2–7 on the left)
or Bgt-Sepharose (lanes 2–7 on
the right). Bgt-Sepharose ap-
peared not to precipitate all of
the a7/5HT3 subunit monomers
precipitated by anti-HA mAb. It
is possible that not all a7/5HT3
subunit monomers assemble
into Bgt-binding complexes
or, alternatively, Bgt-Sepharose
fails to quantitatively precipitate
all Bgt-binding sites. All sam-
ples were loaded on the gels
without DTT, and a sample
from sham-transfected cells (no
DNA) was run in lane 1 (left
and right). Arrows on the right
of the figure indicate positions
of putative monomer, dimer, tri-
mer, tetramer, and pentamer a7/
5HT3-HA subunit complexes.
(B) Addition of 5 mM DTT to
the cell medium blocks Bgt-
binding site formation. The ex-
periment was performed as in
Fig. 4 C except that labeled sub-
units were precipitated with
Bgt-Sepharose.Rakhilin et al. Two Disulfide-bonded Conformations of a7 Subunits 211
precipitated subunits and the change in subunit redox
state as assayed by subunit monomers precipitated with
the anti-HA mAb. Bgt-Sepharose precipitated almost all
a7/5HT3 subunit monomers and smaller amounts of a7/
5HT3 subunit aggregates. Furthermore, the time course of
Bgt-binding site formation and appearance of a7/5HT3
subunit monomers is indistinguishable.
We also tested whether Bgt-binding site formation is
blocked by the addition of DTT after subunit labeling.
Again, 5 mM DTT was added to the medium of cells in
which a7/5HT3 subunits were labeled. The presence of the
DTT blocked the formation of Bgt-binding sites as shown
by the absence of additional Bgt-Sepharose precipitated
subunits after DTT was applied to the medium (Fig. 5 B).
Therefore, intrasubunit disulfide bonding of a7/5HT3 sub-
units is also required for Bgt-binding site formation.
Clearly, Bgt-binding site formation and the redox state
change are closely linked events during a7/5HT3 receptor
assembly as shown by the block of both events by DTT
and their close correlation in time.
a7 and a7/5HT3 Bgt-binding Complexes Contain 
Subunits in Different Redox States
Although there is a strong correlation between the ap-
pearance of subunit monomers on gels and the formation
of Bgt-binding sites, Bgt-Sepharose also precipitated sub-
unit aggregates and multimers (Figs. 5 A and 3 D). This
finding indicates that Bgt-binding a7/5HT3 receptors con-
tain a7/5HT3 subunits in both redox states. To further test
whether both conformations are present within a receptor,
we isolated surface Bgt-binding a7/5HT3 receptors. We
had demonstrated previously that the surface receptors
are a uniform population of pentamers with a molecular
mass of 260 kD and that all receptors cooperatively bound
agonist (Rangwala et al., 1997). Intact cells were bound
with cell-impermeant Bgt, and the Bgt-bound receptors
were immunoprecipitated with anti-Bgt antibodies to spe-
cifically isolate surface receptors. The labeled subunits
were analyzed on nonreducing gels and the subunits solu-
bilized in the absence or presence of NEM were compared
(Fig. 6 A). In the absence of NEM, subunit aggregates and
multimers were observed along with subunit monomers.
When alkylated with NEM, aggregates and multimers
were dispersed, which increased the number of subunit
monomers on the gel. Since the surface receptors consist
of a homogenous population of pentamers, we conclude
that surface receptors contain subunits in both redox con-
formations. The approximately twofold increase in mono-
mers with NEM alkylation further demonstrates that a
significant number of a7/5HT3 subunits in Bgt-bound, sur-
face receptors are found in both redox states.
PC12 and SH-SY5Y cell lines were used to look at the
processing of a7 subunits in cells that produce functional,
Bgt-binding a7 receptors. The PC12 cells have endoge-
nous Bgt-binding receptors that contain a7 subunits (Blu-
menthal et al., 1997; Rangwala et al., 1997) whereas the
SH-SY5Y cells stably express rat a7 subunits in addition
to endogenous a7 subunits (Peng et al., 1994; Puchacz et
al., 1994). The a7 subunits in these cell lines lack the HA
epitope and the level of subunit synthesis is not as high as
that achieved by transient transfection. These differences
prevented us from characterizing a7 subunits in these cell
lines to the same degree as the a7-HA and a7/5HT3-HA
subunits in tsA201 cells. Nonetheless, we were able to pre-
cipitate a7 subunits from SH-SY5Y and PC12 cells using
Bgt-Sepharose and performed Western blot analysis on
the a7 subunits from both cell lines (Fig. 6, B and C). The
processing of a7 subunits in SH-SY5Y and PC12 cells was
different from that of a7 subunits in tsA201 cells. In the
absence of NEM alkylation, many a7 subunits in these
cells migrated as monomers on a nonreducing gel (Fig. 6,
B and C, lane 1). Such monomers were never observed on
nonreducing gels with the expression of the a7-HA sub-
units in tsA201 cells. In addition to the monomers, there
were subunit aggregates and multimers. Like Bgt-binding
a7/5HT3 subunits in tsA201 cells (Fig. 3 D), the a7 subunit
multimers, precipitated with Bgt-affinity resin, were dis-
persed by NEM alkylation and reduction (Fig. 6, B and C,
lane 2). Identical results were found for cell-surface PC12
BgtRs specifically isolated by binding Bgt to intact cells
and immunoprecipitating the Bgt-bound receptors with
anti-Bgt antibodies (Fig. 6 C, lanes 4 and 5).
a7 subunits isolated from SH-SY5Y and PC12 cells dif-
fered from a7 and a7/5HT3 subunit from tsA201 cells in
that the subunits migrated as a doublet after NEM alkyla-
tion on reducing gels (Fig. 6 B, lane 2, and C, lanes 2 and
4). Both doublet bands are recognized by a7-specific anti-
bodies on the Western blots and thus are different forms
of the a7 subunit. Under the same conditions, the doublet
bands are also observed with the metabolically labeled
subunits (data not shown). The lower band of the doublet
migrated precisely at the same position as the tsA201-
expressed a7-HA subunit monomer band (Fig. 6, B and C,
lane 3). The lower band, therefore, corresponds to the a7
subunit form observed in tsA201 cells, which migrates at
this position only when NEM alkylation prevents disulfide
aggregation and cross-linking. The upper band migrates
slower after alkylation than when it is unalkylated (Fig. 6
B, lane 1, and C, lanes 1 and 5), and it is presumed to be in
the second conformational state. It is important to note
that the a7 subunit doublet was observed under conditions
that should eliminate any difference in the redox state of
the subunits, i.e., both NEM alkylation and a reducing gel.
The presence of two a7 subunit bands under these condi-
tions indicates that a7 subunits in these cells are distin-
guished by more than a difference in the redox state of the
subunits.
Discussion
a7 Subunits Fold into Two Different Conformations
In this study, we have compared the processing of a7 and
a7/5HT3 subunits in tsA201 cells. a7/5HT3 subunits un-
dergo different time-dependent processing events that in-
clude a change in subunit redox state and formation of
Bgt-binding sites. These changes were not observed for a7
subunits in tsA201 cells, where the subunits assembled
into receptors that did not function or bind Bgt. However,
a7 subunits did undergo the same changes in SH-SY5Y
and PC12 cells, where they assembled into functional re-
ceptors. After subunit alkylation and reduction, a7 sub-
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separate bands on SDS-PAGE (Fig. 6, B and C). The dif-
ference in migration of the two a7 bands appears to be due
to differential processing. The a7 subunits in the lower
band migrated in the same position as the unprocessed
subunits from the tsA201 cells. The a7 subunits in the up-
per band, thus, correspond to subunits that have under-
gone the processing that results in the redox state change.
Another difference observed for the a7 and a7/5HT3 sub-
units was that subunit complexes lacking Bgt-binding sites
remain associated during SDS-PAGE after reduction and
alkylation (Fig. 3, A and C), whereas Bgt-binding com-
plexes were dispersed under the same conditions (Fig. 3 D
and Fig. 6). These two differences observed for fully al-
kylated and reduced subunits, separation into two bands
during SDS-PAGE, and the change in subunit associations
when exposed to SDS, indicate that subunit processing
causes a change more extensive than a difference in redox
state.
Surface Bgt-binding a7/5HT3 receptors, surface Bgt-
binding  a7 receptors from PC12 cells, and Bgt-binding a7
receptors from SH-SY5Y cells all contain significant num-
bers of subunits in both conformations from which we con-
cluded that each receptor has subunits in two conforma-
tions. An alternative interpretation of the data is that
there are two independent populations of Bgt-binding re-
ceptors, each population with subunits in one of the two
conformational states. Several of our findings are inconsis-
tent with this possibility. In tsA201 cells, a7 subunits as-
semble into pentamers that consist of subunits only in the
initial conformation, and these receptors do not bind Bgt.
Additionally, Bgt-binding sites on a7/5HT3 subunits ap-
pear only as a7/5HT3 subunits change conformation from
the first to the second state (Fig. 5 A). It is, therefore, un-
likely that there is a population of Bgt-binding receptors
with subunits only in the first conformation. Another pos-
sible interpretation of the data is that a7 and a7/5HT3 sub-
Figure 6. Surface a7/5HT3 and a7 subunit receptors from
SH-SY5Y and PC-12 cells contain subunits in two conforma-
tions. (A) Surface Bgt-binding receptors contain subunits in
different redox states. TsA201 cells, transfected with a7/
5HT3-HA cDNAs, were metabolically labeled for 1 h and
chased for 2 h. Cells were surface labeled with Bgt and solubi-
lized in the absence (lane 1) or presence (lane 2) of 2 mM
NEM. The Bgt-bound receptors were specifically precipitated
with anti-Bgt polyclonal antiserum. Arrows on the right of
the figure indicate positions of putative monomer, dimer, tri-
mer, tetramer, and pentamer a7/5HT3-HA subunit com-
plexes. (B) a7 subunits expressed in SH-SY5Y cells. a7 sub-
units stably expressed in SH-SY5Y cells were analyzed by
Western blots. Cells were solubilized in the absence (lane 1)
or presence (lane 2) of 2 mM NEM and subunits were precip-
itated using Bgt-Sepharose. The proteins were transferred to
a nitrocellulose membrane and probed with the a7 subunit-spe-
cific polyclonal antiserum, C-20. Equal samples were loaded
on a SDS polyacrylamide gel either directly (lane 1), or prein-
cubated with 1 mM DTT before loading and then treated with
2 mM NEM (lane 2). For lane 3, tsA201 cells were transfected
with a7-HA cDNA, metabolically labeled, and precipitated
as in Fig. 3 A. The sample was loaded on the same SDS poly-
acrylamide gel after treatment with 1 mM DTT and then with
2 mM NEM. (C) a7 subunits expressed in PC12 cells. a7 sub-
units expressed endogenously in PC12 cells were analyzed by
Western blots. Cells were solubilized in the absence (lanes 1
and 4) or presence (lanes 2 and 5) of 2 mM NEM. Receptors
were either precipitated with Bgt-Sepharose (whole cell;
lanes 1 and 2) or cell-surface, Bgt-bound receptors were se-
lectively precipitated with anti-Bgt protein A–Sepharose
(surface; lanes 4 and 5). The proteins were transferred to a ni-
trocellulose membrane and probed with the a7 subunit-spe-
cific polyclonal antiserum, C-20. Equal samples were loaded
onto an SDS polyacrylamide gel either directly (lanes 1 and
4), or preincubated with 1 mM DTT before loading and then
treated with 2 mM NEM (lanes 2 and 5). For lane 3, tsA201
cells were transfected with a7-HA cDNA, metabolically la-
beled, and precipitated as in Fig. 3 A. The sample was loaded
on the same SDS polyacrylamide gel after preincubation with
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units are in a single conformation that can form subunit
aggregates and multimers, but does so incompletely. If a7
and a7/5HT3 were in such a single conformation, then the
relative amounts of subunit aggregates, multimers, and
monomers on the gels should not significantly depend on
either the time after their synthesis or cell type. However,
we found that following subunit synthesis in tsA201 cells,
a7/5HT3 subunit aggregation decreased as monomers in-
creased with time. In the same cell line, a7 subunits re-
mained as aggregates, whereas in SH-SY5Y and PC12
cells, all forms of the a7 subunits were observed. Thus,
based on all of the data, we conclude that a7 and a7/5HT3
Bgt-binding receptors contain subunits in both conforma-
tions. Since only functional receptors contain subunits in
the two conformations, both conformations appear to be
needed for function.
There is little precedence for our finding that functional
a7 subunit receptors contain subunits that are the same
gene product folded into different conformations. It is
generally assumed that a single, stable conformation is
the end result of the folding process of any protein. Pro-
tein folding into alternative conformations is usually asso-
ciated with a pathological state, a good example being
prion proteins (Prusiner et al., 1998). Similarly, it has
been shown that receptor and ion channel subunits folded
into alternative conformations are defective and are rap-
idly degraded by mechanisms associated with the ER. The
DF508 mutation of the cystic fibrosis transmembrane reg-
ulator (CFTR) ion channel, the most common cause of
cystic fibrosis, is not inserted into the plasma membrane.
Instead, it is rapidly degraded in the ER because of
altered folding that prevents its release from the ER
(Cheng et al., 1990). The Torpedo AChR subunits ex-
pressed in mouse fibroblasts also are not properly folded
and are rapidly degraded (Claudio et al., 1989). In both
cases, altered folding is a temperature sensitive defect
that can be overcome by lowering the temperature (Clau-
dio et al., 1987; Denning et al., 1992). The a7 subunit fold-
ing events that lead to the conformational change also ap-
pear to occur in the ER. This location is suggested since
the conformational change involves intrasubunit disulfide
bonding, a processing event that would be expected to oc-
cur in the oxidizing environment of the lumen of the ER
(Braakman et al., 1991). Also, Bgt-binding site formation
of the muscle AChR occurs in the ER (Smith et al., 1987;
Gu et al., 1989; Ross et al., 1991) and has a time course
very similar to that of the a7/5HT3 subunit receptor (Mer-
lie and Lindstrom, 1983). An important difference be-
tween the folding of the a7 subunit and either the mutant
cystic fibrosis transmembrane regulator (CFTR) or Tor-
pedo AChR subunits is that two different a7 subunit con-
formations are assembled into functional receptors. Thus,
neither a7 subunit conformation is defective, and both a7
subunit conformations are recognized by the cell’s quality
control mechanisms as properly folded versions of the
same gene product.
Disulfide Bonding in the NH2-terminal, Extracellular 
Domain of the a7 Subunit
Several of our findings together with conserved features of
the AChR subunits make it likely that cysteine residues in
the subunit’s NH2-terminal, extracellular domain are in-
volved in the change in redox state (Fig. 7 A). First, trun-
cated a7 subunits, consisting only of this NH2-terminal, ex-
tracellular domain, form disulfide-bonded aggregates and
multimers similar to the full-length a7 subunits (Fig. 3, E
and F). This finding indicates the free sulfhydryl groups
that cross-link the subunits during solubilization are lo-
cated within this domain. Second, DTT applied to the in-
tact cells prevented the time-dependent change in redox
state caused by intrasubunit disulfide bonding of the a7/
5HT3 subunits (Fig. 4 C). Based on the membrane topol-
ogy of a7 and a7/5HT3 subunits (Fig. 7 A), the only cys-
teines accessible to the ER lumen, and thus available for
intrasubunit disulfide bonding, are within the subunit’s
NH2-terminal, extracellular domain. Moreover, it is only
this domain that is shared by a7 and a7/5HT3 subunits,
and there is no homology between a7 and 5HT3 subunits
with respect to the cysteine residues in the COOH-termi-
nal half of the proteins. Further evidence that the redox
state change is caused by disulfide bonding in the subunit’s
NH2-terminal domain is that the only two disulfide bonds
shown to occur on any AChR subunit are located in
highly conserved regions within this domain (Fig. 7 A).
One of the disulfides is a 15–amino acid cystine loop found
on every ACh, 5HT3, g-aminobutyric acid-A (GABAA),
and glycine receptor subunit. The other disulfide is be-
tween adjacent cysteines at the ACh-binding site (Kao and
Karlin, 1986). For a1 subunits, Bgt site formation requires
an intact cystine loop (Mishina et al., 1985; Sumikawa and
Gehle, 1992). Bgt site formation does not correlate with
the act of forming the disulfide bond, but instead with a
subsequent change in a1 subunit conformation which al-
ters antibody accessibility to the loop region (Green and
Wanamaker, 1997). If similar events occur for the a7 sub-
unit, a conformational change would help to catalyze for-
mation of the cystine loop on a7 subunits, which, in turn,
would promote a conformational change leading to Bgt-
binding site formation.
A model of the two a7 subunit conformations is de-
picted in Fig. 7 A. In the SH state, we envision that cys-
teine residues in the loop region are buried, preventing ox-
idation before disulfide bond formation. In the S-S state,
the cysteine residues are brought together and become
more accessible to the oxidizing ER environment, which
catalyzes disulfide bonding. An important feature of this
model is that a conformational change occurs that changes
the environment of the cysteines before disulfide bonding
can occur. a7 subunits differ from virtually every other
AChR subunit in that they lack an N-linked glycosylation
site consensus sequence within their cystine loop region.
Furthermore, compared to a1 subunits, there is an extra
cysteine residue within the NH2-terminal domain of a7
subunits. The fifth cysteine residue, at position 112 (Fig. 7
A), is adjacent to an N-linked glycosylation site. A muta-
tion that removes this glycosylation site causes a loss of
Bgt-binding site expression in Xenopus oocytes, but does
not appear to decrease either subunit synthesis or surface
expression (Chen et al., 1998). These results raise the pos-
sibility that there is no cystine loop between cysteines 128
and 142 in the SH state of the subunit because an alterna-
tive cystine between the cysteines 112 and 128 is formed
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Figure 7. a7 subunits fold and assemble by two different pathways. (A) a7 subunits fold into two conformations. Based on the disulfide
bonding of the AChR a1 subunit (Karlin and Akabas, 1995) shown on the top of the figure, a structural interpretation of the a7 subunit
redox state change is shown. In the SH conformation, we envision that the 15–amino acid cystine loop is not formed and the two cys-
teines at residues 128 and 142 are not oxidized. In the S-S conformation, a disulfide bond has formed between these two cysteines. TheRakhilin et al. Two Disulfide-bonded Conformations of a7 Subunits 215
The Regulation of a7 Subunit Processing
A consequence of a7 subunit folding into two conforma-
tions is that receptors with different properties can be as-
sembled by at least two different pathways. Two such
pathways are diagrammed in Fig. 7 B. We have called the
path by which a7 subunits assemble when heterologously
expressed in most cells the default pathway because the
subunits assemble together without additional processing.
Along this path, subunits in the SH conformation are as-
sembled into pentamers, presumably in the ER, and the
resultant receptors can neither function nor bind Bgt. In
SH-SY5Y and in PC12 cells, both the SH and S-S a7 con-
formations are produced, leading to pentamers that func-
tion and bind Bgt. Since assembly along this pathway re-
quires the additional subunit processing that does not
occur in certain cells, we have termed this the regulated
pathway of assembly. The question marks are included in
Fig. 7 B because we have not determined whether the sub-
units undergo the conformational change before, during,
or after assembly into pentamers.
Although neither the Bgt- nor ACh-binding sites lie
within the COOH-terminal half of the a7 subunit, this re-
gion of the subunit plays a critical role in determining
whether receptors bind Bgt and are activated by agonist.
In tsA201 cells, receptor function and Bgt binding are only
observed when the COOH-terminal half of the a7 subunit
is replaced with the COOH-terminal half of the 5HT3 sub-
unit. Somehow, the COOH-terminal half of the subunit
regulates the conformational state of the subunit’s extra-
cellular NH2-terminal half and determines whether a
change in redox state and Bgt-binding site formation can
occur. If only the NH2-terminal half of the a7 subunit is
expressed, the truncated a7 subunits undergo the redox
state change (Fig. 3 E). This finding further suggests that
the a7 subunit COOH-terminal half, in an unmodified
state, prevents the conformational change. We can only
speculate on the mechanisms that alter the COOH-termi-
nal half of the subunit and, in turn, regulate whether the
subunit changes conformation. An attractive hypothesis is
that modification of the cytoplasmic domain that lies be-
tween the third and fourth membrane spanning regions,
regulates the subunit conformation (Fig. 7 A). Within this
cytoplasmic domain, there are consensus sequences for
different kinds of protein phosphorylation. There is also
evidence that proline isomerization of a7 subunits by cy-
clophilin A is necessary for the expression of functional a7
subunit receptors (Helekar et al., 1994; Helekar and
Patrick, 1997). However, there is additional evidence that
cyclophilin-mediated proline isomerization is not suffi-
cient to cause expression of Bgt-binding receptors in ei-
ther HEK 293 cells or PC12 cells (Blumenthal et al., 1997;
Cooper and Millar, 1997).
One feature of the regulation of the a7 subunit is that it
is cell-type specific. In most cell lines, heterologous ex-
pression of a7 subunits results in little to no production of
functional receptors or Bgt binding (Cooper and Millar,
1997; Rangwala et al., 1997). Yet, heterologous expression
of a7 subunits in cell lines of neuronal or neuroendocrine
origin, such as SH-SY5Y cells (Puchacz et al., 1994), PC12
(Blumenthal et al., 1997; Cooper and Millar, 1997), and
GH4 cells (Quik et al., 1996), produces functional, Bgt-
binding receptors. Note that there are cell lines of neu-
ronal origin in which functional a7 subunit receptors are
not expressed (Cooper and Millar, 1997). Furthermore,
heterologous expression of Bgt-binding receptors only oc-
curs in PC12 cell isolates where native Bgt-binding sites
are found (Blumenthal et al., 1997). Taken together with
the findings of this paper, these results suggest that the
regulatory mechanisms changing the a7 subunit conforma-
tion are restricted to a subset of neurons and neuroendo-
crine cells, and they act to determine when and where
functional, Bgt-binding receptors are produced.
Why are nonfunctional a7 subunit receptors assembled
in cells such as the tsA201 cells? One possibility is that the
receptors assembled by the default pathway can be trans-
formed into functional receptors, either during transport
to the cell surface or after insertion into the plasma mem-
brane. Consistent with this possibility are studies showing
that some neuronal AChRs are inserted into the plasma
membrane in a nonfunctional state after which the recep-
tors are converted into a functional state (Margiotta et al.,
1987; Higgins and Berg, 1988). Another possible explana-
tion is that a7 subunits in the SH conformation can assem-
ble with other AChR subunit isoforms, but that these sub-
units are absent in the tsA201 cells. Studies indicating that
a7 subunits in cultured chick sympathetic neurons can as-
semble with other AChR subunits support this possibility
(Listerud et al., 1991).
a7 Subunit Diversity and Distinguishable
ACh-binding Sites
The results of this paper may help to explain how a homo-
meric receptor can have several ligand-binding sites with
distinguishable features. In a recent paper (Rangwala et al.,
arrows mark residues in this region of the a7 subunit that are different from other AChR subunits. These residues are an aspartate at
position 141 that replaces an asparagine and removes a conserved consensus site for N-linked glycosylation at residue 141, a fifth cys-
teine residue at position 112 not found on other AChR a subunits, and an asparagine at residue 107 that creates a consensus site for
N-linked glycosylation at residue 107. Our results suggest that changes in the conformation of the NH2-terminal domain allow the disul-
fide bonding. The NH2-terminal domain conformational changes appear to be driven by changes in the conformation of the COOH-ter-
minal half of the subunit, perhaps changes in the COOH-terminal half cytoplasmic domain as depicted in the figure. (B) Assembly of a7
subunit complexes by different pathways. As depicted in the figure, we have found that a7 subunits can fold and assemble into two con-
formations. In tsA201 cells, a7 subunits assemble by a default pathway since they remain in a single conformation, SH, and assemble
into pentamers that are neither functional nor bind Bgt. In SH-SY5Y and PC-12 cells, a7 subunits fold into a second conformation, S-S,
and assemble with subunits in the SH conformation into pentamers that function and bind Bgt. The question marks are included in the
figure because it is unclear whether the subunits undergo the conformational change before, during, or after assembly into pentamers. If
it is assumed that ACh-binding sites can form on S-S subunits at their interface with other subunits, then distinguishable sites can form
at interfaces between S-S subunits (open ellipses) and between S-S and SH subunits (filled ellipses).The Journal of Cell Biology, Volume 146, 1999 216
1997), we found that the ACh-binding sites of a7/5HT3
receptors and the a7 receptors from PC12 cells were dis-
tinguishable, similar to the ACh-binding sites of mus-
cle AChRs. Muscle AChRs are heteroligomers with two
ACh-binding sites that are located at the interface be-
tween  a1 and other subunits. The differences between the
two muscle AChR ACh-binding sites are caused by the as-
sociation of a1 subunits with two different subunits, either
g or d (Blount and Merlie, 1989; Pedersen and Cohen,
1990). As shown in Fig. 7 B, a receptor composed of one
subunit in the SH conformation interspersed with four
subunits in the S-S conformation could give rise to two dif-
ferent classes of ACh-binding sites. If it is assumed, as with
the muscle AChR, that there is one ACh-binding site for
each S-S subunit at or near the interface between subunits,
ACh-binding sites would exist at two different subunit in-
terfaces. Of the four ACh-binding sites, one would be at
the interface between S-S and SH subunits and four at in-
terfaces between two S-S subunits. Generation of two dif-
ferent a7 subunit conformations thus creates two different
subunit interfaces which, in analogy with the muscle
AChR, are needed to form ACh-binding sites with differ-
ent affinities. By conferring on the receptor the ability to
form distinguishable binding sites, different a7 subunit
conformations would serve the same function as different
AChR subunit isoforms. For oligomeric receptors and ion
channels, subunit diversity can be generated by transcrip-
tion of different subunit genes, alternative mRNA splic-
ing, and mRNA editing mechanisms. Our results suggest
that protein folding is another mechanism by which differ-
ences in subunits are generated.
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